1. Home
  2. MSGM vs LPCN Comparison

MSGM vs LPCN Comparison

Compare MSGM & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

N/A

Current Price

$3.16

Market Cap

13.4M

Sector

Technology

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$3.70

Market Cap

13.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSGM
LPCN
Founded
2018
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
13.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MSGM
LPCN
Price
$3.16
$3.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
105.5K
47.0K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.81
N/A
Revenue
$9,424,138.00
$4,322,693.00
Revenue This Year
$69.07
N/A
Revenue Next Year
$30.56
N/A
P/E Ratio
$3.45
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.73
$2.52
52 Week High
$5.41
$5.50

Technical Indicators

Market Signals
Indicator
MSGM
LPCN
Relative Strength Index (RSI) 58.36 70.73
Support Level $2.66 $3.05
Resistance Level $2.83 $3.39
Average True Range (ATR) 0.17 0.18
MACD 0.03 0.01
Stochastic Oscillator 71.90 75.79

Price Performance

Historical Comparison
MSGM
LPCN

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: